Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

Bardy-Bouxin N, Matczak E, Devgan G, Woloj M, Shapiro M

Biologics: Targets and Therapy 2015, 9:23-24

Published Date: 19 February 2015